Search

everythinglearnresearchcommunity

for

Search:↓

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Hair loss in men treated best with early medication or transplant, new treatments researched.

Using human fat tissue derived stem cells in micrografts can safely and effectively increase hair density in people with hair loss.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

Memantine may slightly improve memory in people with Down syndrome, but more research is needed.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

Skin grafts are effective for chronic leg ulcers, especially autologous split-thickness grafts for venous ulcers, but more data is needed for diabetic ulcers.

Finasteride reduces hair loss and treats BPH without major hormone changes, but may cause sexual dysfunction.

Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.

Certain drugs that block specific enzymes can help treat prostate diseases.

Botulinum toxin has potential for treating various skin conditions and improving wound healing.

Drug repositioning is becoming more targeted and efficient with new technologies, offering personalized treatment options and growing interest in the field.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

The document concludes that while lab results for hair growth promotion are promising, human trials are needed and better testing methods should be developed.

Chitosan/LiCl composite scaffolds help heal deep skin wounds better.

The PCOS-specific questionnaire needs more work to fully measure quality of life in clinical trials.

Using computers to analyze drugs can find new uses for them, but actual experiments are needed to confirm these uses.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

Managing PCOS is hard because it varies a lot, treatments are limited, and there's a lot of false information online.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Removing a methyl group from the ITGAV gene speeds up bone formation in a specific type of bone disease model.

Cynatine HNS improves hair and nail quality in 90 days.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

The document concludes that regenerating functional ectodermal organs like teeth and hair is promising for future therapies.

The article concludes that a balance is needed between individual healthcare needs and societal resources when it comes to lifestyle drugs, with a call for compassionate policy application.

Low-level laser therapy can improve hair density in people with androgenic alopecia, but more research is needed to find out who it works best for.